A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression

por Meraviglia-Crivelli, Daniel, Villanueva, Helena, Menon, Ashwathi Puravankara, Zheleva, Angelina, Moreno, Beatriz, Villalba-Esparza, María, Pastor, Fernando
Publicado 2022

Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

por Sola, Mayte, Menon, Ashwathi Puravankara, Moreno, Beatriz, Meraviglia-Crivelli, Daniel, Soldevilla, Mario Martínez, Cartón-García, Fernando, Pastor, Fernando
Publicado 2020

Modulating T Cell Responses by Targeting CD3

por Menon, Ashwathi Puravankara, Moreno, Beatriz, Meraviglia-Crivelli, Daniel, Nonatelli, Francesca, Villanueva, Helena, Barainka, Martin, Zheleva, Angelina, van Santen, Hisse M., Pastor, Fernando
Publicado 2023

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

por Soldevilla, Mario Martínez, Villanueva, Helena, Meraviglia-Crivelli, Daniel, Menon, Ashwathi Puravankara, Ruiz, Marta, Cebollero, Javier, Villalba, María, Moreno, Beatriz, Lozano, Teresa, Llopiz, Diana, Pejenaute, Álvaro, Sarobe, Pablo, Pastor, Fernando
Publicado 2019

IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction

por Meraviglia-Crivelli, Daniel, Villanueva, Helena, Zheleva, Angelina, Villalba-Esparza, María, Moreno, Beatriz, Menon, Ashwathi Puravankara, Calvo, Alfonso, Cebollero, Javier, Barainka, Martin, de los Mozos, Igor Ruiz, Huesa-Berral, Carlos, Pastor, Fernando
Publicado 2022